Keke Wu focuses her practice on advising corporate clients and investment banks on capital markets transactions, such as initial public offerings, investment-grade bond offerings and high-yield bond offerings.

Download full bio 

Experience

  • Asymchem Agrees to Acquire Snapdragon Chemistry 

  • Asymchem Laboratories – HK$7.15 Billion IPO 

Education

  • Harvard Law School
    JD, 2018

  • University of International Business and Economics
    LLB, 2015


Admissions & Credentials

New York

Media & Insight